5LO0
HSP90 WITH indazole derivative
Summary for 5LO0
Entry DOI | 10.2210/pdb5lo0/pdb |
Related | 4EEH |
Descriptor | Heat shock protein HSP 90-alpha, [2-azanyl-6-[4,5-bis(fluoranyl)-2-(4-methylpiperazin-1-yl)sulfonyl-phenyl]quinazolin-4-yl]-(1,3-dihydroisoindol-2-yl)methanone (3 entities in total) |
Functional Keywords | chaperone |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 26278.43 |
Authors | Graedler, U.,Amaral, M.,Schuetz, D. (deposition date: 2016-08-08, release date: 2017-11-29, Last modification date: 2024-01-10) |
Primary citation | Schuetz, D.A.,Richter, L.,Amaral, M.,Grandits, M.,Gradler, U.,Musil, D.,Buchstaller, H.P.,Eggenweiler, H.M.,Frech, M.,Ecker, G.F. Ligand Desolvation Steers On-Rate and Impacts Drug Residence Time of Heat Shock Protein 90 (Hsp90) Inhibitors. J. Med. Chem., 61:4397-4411, 2018 Cited by PubMed: 29701469DOI: 10.1021/acs.jmedchem.8b00080 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.3 Å) |
Structure validation
Download full validation report